Evaluating the abilities of diverse nitroaromatic prodrug metabolites to exit a model Gram negative vector for bacterial-directed enzyme-prodrug therapy. [electronic resource]
- Biochemical pharmacology 12 2018
- 192-200 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-2968
10.1016/j.bcp.2018.10.020 doi
Aziridines--metabolism Dose-Response Relationship, Drug Drug Evaluation, Preclinical--methods Escherichia coli--drug effects Genetic Therapy--methods Genetic Vectors--metabolism Humans Nitroreductases--metabolism Prodrugs--metabolism